Equity Research firms currently have a positive stance on shares of MEDNAX, Inc. (NYSE:MD). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.20. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $74.00 on a short term basis.
At the time of writing, the stock was trading at $65.52. This represents a change from the opening price of -0.08%. In terms of performance, year to date, the stock is -8.05%. The monthly stock performance comes in at 2.19%. For the quarter, shares are performing at -9.32%. Weekly performance analysis shows the equity at 1.35%.
In taking a look at technical levels, shares are trading -1.30% away from the 50 day simple moving average and -3.74% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -21.25% away from it’s 52- week high and 6.71% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, MEDNAX, Inc.’s RSI stands at 48.69. In looking at volatility levels, the shares saw weekly volatility of 1.42% and 1.71% over the past month.